Search Within

Surgery

Formats
  1. Journal Article (13376)
  2. Meeting Abstract (4888)
  3. Book Section (1164)
  4. Review (598)
  5. Editorial (578)
  6. Conference Paper (250)
  7. Correspondence (159)
  8. Miscellaneous (144)
  9. Guidelines (130)
  10. Book Whole (93)
  11. Research Letter (64)
Groups
  1. Survivorship Research (5189)
  2. Department of Medicine (4913)
  3. Urology (4539)
  4. Solid Tumor Oncology Division (4054)
  5. Epidemiology and Biostatistics (3716)
  6. Department of Pathology and Laboratory Medicine (3658)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (909)
  3. Nadeem Abu-Rustum (894)
  4. Valerie Rusch (869)
  5. Michael D'Angelica (783)
  6. Monica Morrow (777)

More People

Years
  1. 2025 (548)
  2. 2024 (989)
  3. 2023 (931)
  4. 2022 (1036)
  5. 2021 (955)
  6. 2020 (925)

More Years

Publications
  1. Journal of Clinical Oncology (1564)
  2. Annals of Surgical Oncology (1525)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (553)
  5. International Journal of Radiation Oncology, Biology, Physics (461)
  6. Cancer (425)

More Publications

Publishers
  1. Elsevier Inc. (3571)
  2. Springer (2704)
  3. Elsevier Science, Inc. (2071)
  4. Lippincott Williams & Wilkins (1689)
  5. American Society of Clinical Oncology (1661)
  6. Wiley Blackwell (1238)

More Publishers

Results (21444)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Trivedi, N.; Maron, S. B.; Joshi, S. S.; Ilson, D. H.; Janjigian, Y. Y.; Shcherba, M.; Li, J.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
    Meeting Abstract

    Janjigian, Y. Y.; Al-Batran, S. E.; Wainberg, Z. A.; Van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L. S.; Oh, D. Y.; Omori, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Identification of somatic alterations associated with brain metastases from a colorectal origin
    Meeting Abstract

    Strong, J. S.; Drebin, H. M.; Walch, H. S.; Gui, C.; Pike, L. R. G.; Moss, N. S.; Sanchez-Vega, F.; Smith, J. J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • An online rectal cancer tumoroid biorepository: A resource to facilitate multimodal data integration
    Meeting Abstract

    Alvarez, J.; Zambare, W.; Wu, C.; Bleu, P.; Bercz, A.; Satravada, B.; Kundra, R.; De Bruijn, I.; Schultz, N.; Shia, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intrahepatic cholangiocarcinoma: Recurrence patterns, genomics and survival
    Meeting Abstract

    Chandra, P.; Song, Y.; Drill, E. N.; Wei, A. C. C.; Kemeny, N. E.; Cercek, A.; Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.; Park, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Diagnostic performance of endoscopy and MRI in identifying true response among patients with rectal cancer treated with total neoadjuvant therapy and selective watch and wait or TME
    Meeting Abstract

    Omer, D. M. R.; Williams, H.; Lin, S. T.; Thompson, H. M.; Verheij, F. S.; Yuval, J. B.; Buckley, J. T.; Qin, L. X.; Gollub, M. J.; Garcia-Aguilar, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Local excision to enhance organ preservation in rectal cancer after favorable response to total neoadjuvant therapy
    Meeting Abstract

    Bercz, A.; Rosen, R.; Drescher, M.; Gonen, M.; Shia, J.; Nishimura, M.; Romesser, P. B.; Crane, C. H.; Saltz, L. B.; Cercek, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enhancing patient selection for salvage radical prostatectomy: A new riskstratification model from a large retrospective cohort
    Meeting Abstract

    Calleris, G.; Marra, G.; Benfant, N.; Rajwa, P.; Ahmed, M.; Ghoreifi, A.; Abreu, A.; Ribeiro, L.; Westhofen, T.; Tourinho-Barbosa, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Analysis of the Tumor MicroEnvironment (TME) in high-grade Ta (HG Ta) bladder cancer reveals an immune and stromal enriched subtype which demonstrates poor prognosis with concurrent carcinoma-in situ (CIS)
    Meeting Abstract

    Mark, F.; Jacob, T.; Pietzak, E.
    European Urology (2024)

    Fulltext@MSK | Save